The Europe Molecular Diagnostics Market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth.
Rising awareness levels among individuals pertaining to the availability of effective molecular diagnostic tests to determine the presence of genetic disorders is expected to increase the client base for this industry, consequently leading to early diagnosis of disorders in the population.
In addition, with the demand for high levels of accuracy and cost effectiveness of diagnostic procedures, the existent technologies are continually undergoing progressive changes to develop improved and efficient testing tools. Presence of a number of established healthcare facilities coupled with the technological advancements facilitating and expediting accurate disease diagnosis are expected to serve this market as significant drivers fueling growth.
Request a sample Copy of the Europe Molecular Diagnostics Market Research Report @ https://www.grandviewresearch.com/industry-analysis/europe-molecular-diagnostics-market/request/rs1
Further key findings from the study suggest:
Have Any Query? Ask Our Experts @ https://www.grandviewresearch.com/inquiry/3084/ibb
Grand View Research has segmented the Europe molecular diagnostics market on the basis of product, technology, applications, test location, and country:
Europe Molecular Diagnostics Product Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Test Location Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Technology Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics PCR, by segments Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Application Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Oncology, By Application Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Infectious Disease, By Application Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Genetic Testing, By Application Outlook (Market Revenue in USD Million, 2013 – 2024)
Europe Molecular Diagnostics Country Outlook (Market Revenue in USD Million, 2013 – 2024)
Browse Related Report:
Heart Attack Diagnostics Market – https://www.grandviewresearch.com/industry-analysis/heart-attack-diagnostics-market
Europe, Middle East, and Africa (EMEA) Point-of-Care (PoC) Diagnostics Market – https://www.grandviewresearch.com/industry-analysis/emea-point-of-care-poc-diagnostics-market
About Grand View Research
Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.
Media ContactCompany Name: Grand View Research, Inc.Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.Email: Send EmailPhone: 1-415-349-0058, Toll Free: 1-888-202-9519Address:201, Spear Street, 1100 City: San FranciscoState: CaliforniaCountry: United StatesWebsite: www.grandviewresearch.com/industry-analysis/europe-molecular-diagnostics-market